CEBPA biallelic mutations, PTPN11, and NRAS mutations are found in approximately equal frequencies between infant and pediatric AML patients, while KRAS mutations predominate in the latter [86]. This evidence concerns the gene PTPN11 and acute myeloid leukemia.